UPDATE: BofA Securities Downgrades Regeneron Pharma (REGN) to Underperform
Tweet Send to a Friend
(Updated - January 5, 2022 7:44 AM EST)
BofA Securities analyst Geoff Meacham downgraded Regeneron Pharma (NASDAQ: REGN) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
BofA Securities analyst Geoff Meacham downgraded Regeneron Pharma (NASDAQ: REGN) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
